The Journal of Neuroscience, July 2, 2003, 23(13):5771-5777
Previous Article | Next Article 
Estrogen Receptor
Mediates Rapid Estrogen Actions on Gonadotropin-Releasing Hormone Neurons In Vivo
István M. Ábrahám,1
Seong-Kyu Han,1
Martin G. Todman,1
Kenneth S. Korach,2 and
Allan E. Herbison1,3
1Laboratory of Neuroendocrinology, The Babraham
Institute, Cambridge CB2 4AT, United Kingdom,
2Receptor Biology Section, Laboratory of Reproductive
and Developmental Toxicology, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina 27709, and
3Centre for Neuroendocrinology, Department of
Physiology, University of Otago School of Medical Sciences, Dunedin, New
Zealand
 |
Abstract
|
|---|
The gonadal steroid estrogen exerts an important modulatory influence on
the activity of multiple neuronal networks. In addition to classical genomic
mechanisms of action, estrogen also exerts poorly understood rapid, nongenomic
effects on neurons. To examine whether estrogen may exert rapid actions on
intracellular signaling within gonadotropin-releasing hormone (GnRH) neurons
in vivo,we examined the phosphorylation status of cAMP response
element-binding protein (CREB) in these cells after the administration of
17-
-estradiol to ovariectomized (OVX) mice. The percentage of GnRH
neurons expressing phosphorylated CREB was increased more than sixfold
(p < 0.05) in a time- and dose-dependent manner by estrogen, with
the increase first observed 15 min after estrogen administration. A series of
in vitro studies demonstrated that estrogen acted directly on native
GnRH neurons to phosphorylate CREB, but that estrogen conjugated to bovine
serum albumin was without effect. The role of classical estrogen receptors
(ERs) was evaluated using ER knock-out mice in vivo. The effect of
estrogen on CREB phosphorylation in GnRH neurons was normal in ER
knock-out mice but completely absent in ER
knock-out mice. Finally,
studies in intact female mice revealed levels of CREB phosphorylation within
GnRH neurons that were equivalent to those of estrogen-treated OVX mice. These
observations demonstrate that ER
mediates the rapid, direct effects of
estrogen on the GnRH neuronal phenotype, and that these actions persist under
physiological conditions. They also provide the first evidence for a role of
ER
in nongenomic estrogen signaling within the brain in
vivo.
Key words: CREB; estrogen; estrogen receptor
; GnRH; LHRH; nongenomic; rapid; transgenics
 |
Introduction
|
|---|
The activity of multiple neuronal networks is influenced by the ovarian
hormone estrogen. Whereas early studies implicated estrogen as a classical
feedback molecule acting to coordinate the activity of networks associated
with reproductive control (Pfaff et al.,
1994
), more recent studies have documented actions of estrogen
throughout the nervous system (McEwen and
Alves, 1999
). In addition to the established physiological roles
of estrogen, recent studies are also highlighting its importance in the
amelioration of neurodegenerative and ischemic insults to the nervous system
(Henderson, 2000
;
Wise et al., 2001
). Although
it remains clear that many of the effects of estrogen occur through the
estrogen receptor (ER) in a classic genomic manner, rapid actions of estrogen
that are considered not to involve transcriptional regulation have also been
demonstrated (Kelly and Wagner,
1999
; McEwen and Alves,
1999
). The nongenomic actions of estrogen have been shown to
involve multiple different intracellular signaling pathways
(Kelly and Levin, 2001
),
although the roles of ER
and ER
in this process remain
controversial.
In the mammalian brain, the gonadotropin-releasing hormone (GnRH) neurons
represent the final output neuron of the network controlling gonadal function.
Not surprisingly, their activity is regulated strongly by the fluctuating
levels of plasma estrogen that exist during the ovarian cycle in the female
(Herbison, 1998
). Precisely
how estrogen regulates the biosynthetic and secretory activity of the GnRH
neurons is not clear, although the recent discovery of low levels of ER
mRNA (Skynner et al., 1999
;
Hrabovszky et al., 2000
) and
protein (Hrabovszky et al.,
2001
; Kallo et al.,
2001
) in these cells has suggested a mechanism for
estrogen-dependent transcriptional control in GnRH neurons
(Herbison and Pape, 2001
).
However, the functional significance of these low levels of ER
in GnRH
neurons remains unknown.
A concerted understanding of the impact of estrogen on any neuronal
phenotype such as the GnRH neuron requires information on the complete
spectrum of genomic and nongenomic estrogenic effects. A previous study by
Lagrange et al. (1995
)
demonstrated rapid effects of estrogen on the electrical excitability of GnRH
neurons in the guinea pig. Using the phosphorylation of cAMP response
element-binding protein (CREB) as an index of changes in intracellular
signaling (Shaywitz and Greenberg,
1999
; West et al.,
2001
), we used multiple in vivo and in vitro
approaches to explore the mechanisms of rapid estrogen signaling in GnRH
neurons. Previous studies have shown that acute estrogen elevates CREB
phosphorylation in the brain (Gu et al.,
1996
; Zhou et al.,
1996
; Carlstrom et al.,
2001
). Our findings demonstrate that estrogen exerts rapid and
direct actions on the GnRH neuronal phenotype, and that this requires estrogen
to pass through the cell membrane and interact with ER
. These studies
provide the first evidence for a functional ER in the GnRH neuron and show
that ER
is involved in nongenomic estrogen signaling within the
brain.
 |
Materials and Methods
|
|---|
Animals
All of the mice were bred and housed at The Babraham Institute according to
the United Kingdom Home Office requirements under Project license 80/1475, and
the experiments were approved by The Babraham Institute Animal Welfare and
Ethics Committee. Mice were maintained under a 12 hr light/dark cycle (lights
on at 7:00 A.M.) with food and water available ad libitum.
Adult female wild-type mice (CBA/Ca x C57BL/6J) were ovariectomized
(OVX) at 4054 d of age under Avertin anesthesia and used for
experiments 23 weeks later. Mice (
20 gm) were administered 1 or 10
µg of 17-
-estradiol (E2) (Sigma, Poole, UK) (in 0.1 ml of ethyl
oleate vehicle, s.c.) or vehicle alone between 10:00 and 11:00 A.M., killed 15
min, 1 hr, or 4 hr later by an overdose of Avertin (0.3 ml/20 gm of body
weight), and perfused through the heart with ice-cold 4% paraformaldehyde
(PFA) in phosphate buffer (PB), pH 7.6. Brains were removed, postfixed for 2
hr, and placed into 30% sucrose Tris-buffered saline (TBS) solution overnight
at 4°C. The following day, a 1:4 series of 30 µm-thick coronal sections
were cut through the septum and hypothalamus on a sliding microtome. Female
homozygous ER
knock-out (KO) mice
(Lubahn et al., 1993
),
ER
KO mice (Krege et al.,
1998
), and wild-type siblings (C57BL/6J) were identified by PCR
and treated in the same manner as detailed above, with the exception that
these mice were treated with only the lower 1 µg E2 dose or vehicle and
killed 1 hr later, with blood taken before perfusion for luteinizing hormone
(LH) radioimmunoassay. In the final study, mice were OVX or given sham surgery
and then anesthetized and perfused 2 weeks later. The estrous stage of
sham-treated mice was assessed by vaginal smear, and those in diestrous were
selected for perfusion alongside the OVX mice. This represents a time when
normal circulating levels of estrogen are
3040 pg/ml
(Bronson, 1981
). Plasma samples
were assayed for LH in duplicate, using reagents provided by National
Institute of Diabetes and Digestive and Kidney Diseases in a single assay. The
assay sensitivity was 0.16 ng/ml, and the intra-assay coefficient of variation
was 8.6%.
Acute brain slice preparation for assessing CREB phosphorylation in
vitro
An acute brain slice protocol was developed for in vitro
investigations on the basis of our electrophysiological brain slice
preparation (Han et al., 2002
).
Two weeks after ovariectomy, wild-type female mice were decapitated at
10:00 A.M., and their brains were rapidly removed and placed in
oxygenated, ice-cold, cutting artificial CSF (ACSF) containing (in
mM): 118 NaCl, 3 KCl, 0.5 CaCl2, 6 MgCl2,11
D-glucose, 10 HEPES, and 25 NaHCO3, pH 7.4 when bubbled
with 95% O25% CO2. Coronal slices (400 µm
thick) were then cut from each brain through the rostral preoptic area (rPOA)
on a vibratome (Campden Instruments, Loughborough, UK), and slices were
preincubated at 30°C for 30 min in oxygenated normal ACSF consisting of
(in mM): 118 NaCl, 3 KCl, 2.5 CaCl2, 1.2
MgCl2, 11 D-glucose, 10 HEPES, and 25 NaHCO3.
In the first experiment, slices were transferred into ACSF containing 100
nM E2 or vehicle (<0.01% ethyl alcohol) with or without 0.5
µM tetrodotoxin (TTX) (Tocris Cookson, Bristol, UK) for 1 hr.
Those slices treated with TTX also had TTX included in the preincubation ACSF.
Estrogen concentrations of 10100 nM are used routinely to
investigate rapid estrogen actions on cells in vitro
(Kelly and Levin, 2001
). In
the second experiment, slices were transferred into either ACSF alone, 100
nM E2, or 100 nM E2BSA (Sigma, Poole, UK) for 1
hr. Free or disassociated E2 was removed from the E2BSA solution
immediately before application by filtration following the protocol of Stevis
et al. (1999
). At the end of
the 1 hr treatments, all of the slices were fixed in 4% PFA in PB at 4°C
overnight. The next day, slices were transferred into 30% sucroseTBS
for 3 hr, and two sets of 30 µm-thick coronal sections were cut on a
freezing microtome.
Immunocytochemistry
CREB immunocytochemistry. Free-floating, double-labeling,
peroxidase immunocytochemistry was performed in the same manner as reported
previously (Pape et al.,
1999
). In brief, after a 0.1% H2O240%
methanolTBS wash, all of the sections from one set were incubated in
one of the primary antibodies [phosphorylated CREB (pCREB), 1:100; CREB,
1:100; Cell Signaling Technology, New England Biolabs, Hitchin, UK] for 48 hr
at 4°C. This was followed by biotinylated goat anti-rabbit IgGs (1:200 for
2 hr; Vector Laboratories, Peterborough, UK) and the Vector Elite
avidinbiotinHRP complex (1:200 for 2 hr). Peroxidase labeling
was then visualized with nickel-diaminobenzidine tetrahydrocloride (DAB) using
glucose oxidase. Sections were then processed further for GnRH
immunoreactivity with the LR1 antibody (1:20,000) followed by
peroxidase-labeled anti-rabbit IgGs and revealed using DAB only. The
specificities of the CREB antibodies have been reported previously in multiple
rodent species (McNulty et al.,
1998
) (Cell Signaling Technology data), including the mouse
(von Gall et al., 1998
). The
omission of primary antibodies in these studies resulted in a complete absence
of immunoreactivity.
Analysis. Sections were examined under a Leica (Nussloch, Germany)
DM-RB microscope at 1040x objective magnification. GnRH neurons
located in the medial septum (MS), rPOA, and anterior hypothalamus (AH) were
examined in in vivo experiments, while sections from the rPOA were
analyzed in in vitro experiments. Two sections representing each
level were selected from each animal, and the number of single (GnRH) and
double-labeled (GnRH plus pCREB or GnRH plus CREB) neurons was determined by
an investigator blind to the experimental groupings. We only considered a GnRH
neuron to be expressing CREBpCREB if the nucleus displayed a uniform,
dense-black immunoreactivity product. Although likely to underrepresent
absolute CREBpCREB expression in the GnRH neurons, this ensured
consistency in our counting analysis. The mean values from each mouse were
used to provide group means (+SEMs). The CREB and pCREB expression in GnRH
neurons was calculated as a percentage of GnRH neurons at each level and also
as a percentage of all of the GnRH neurons examined. Analysis of CREB and
pCREB immunoreactivity in the anteroventral periventricular nucleus (AVPV) and
CA1 region of the hippocampus was performed using a computer-assisted AIS 6.0
image analyzer (Imaging Research, St. Catharines, Ontario, Canada) with images
digitized using a Sony (Tokyo, Japan) charge-coupled device camera. Cell
counts were performed bilaterally within the defined area (AVPV, 0.03 mm
2; CA1, 1.5 mm 2) on two sections from each mouse. The
anterioposterior levels for each region were plate 29 for the AVPV and plate
50 for the CA1 according to Paxinos and Franklin
(2001
).
To examine the differences between groups in the E2 doseresponse
study and in E2BSA, a statistical analysis was performed by one-way
ANOVA with StudentNewmanKeuls post hoc tests. Two-way
ANOVA with StudentNewmanKeuls post hoc test was used to
determine differences between groups in all of the other experiments.
 |
Results
|
|---|
Estrogen rapidly phosphorylates CREB in GnRH neurons in
vivo
Time course
Immunoreactivity for CREB and pCREB was restricted to cell nuclei and
readily detected in GnRH neurons with double-labeling immunocytochemistry
(Fig. 1). The administration of
10 µg of E2 to OVX wild-type mice resulted in a significant (p
< 0.05) sixfold to sevenfold increase in pCREB expression by GnRH neurons
15 min, 1 hr, and 4 hr later, with an apparent maximal increase observed at 1
hr (Fig. 1B). The
expression of CREB by GnRH neurons was not changed
(Fig. 1A). The same
patterns of CREB and pCREB expression were observed in GnRH neurons
irrespective of their location within the MS, rPOA, or AH (data not shown).
The total numbers of GnRH neurons detected varied according to anatomical
location (MS, 7.3 ± 1; rPOA, 19 ± 1.2; AH, 5.6 ± 0.6 GnRH
neurons/section) but were not altered by estrogen treatment or time (data not
shown).

View larger version (56K):
[in this window]
[in a new window]
|
Figure 1. Estrogen rapidly phosphorylates CREB within GnRH neurons in a time- and
dose-dependent manner in vivo. Histograms show the percentage of GnRH
neurons expressing CREB (A) and pCREB (B) immunoreactivity
15 min, 1 hr, and 4 hr after the administration of vehicle (V) (open bars) or
10µg of E2 (filled bars) to ovariectomized mice. C, The percentage
increment in the numbers of GnRH neurons expressing pCREB immunoreactivity 1
hr after 1 or 10µg of E2 (filled bars) compared with vehicle-treated mice
(V) (open bars). D, Photomicrograph shows nuclear pCREB
immunoreactivity (black) and a double-labeled GnRH neuron (brown cytoplasm).
Scale bar, 20 µm. *p < 0.05; n = 59
in all of the groups. Histograms show mean ± SEM.
|
|
Dose dependence
The administration of 1 and 10 µg doses of E2 to OVX mice evoked a clear
dose-dependent increase in pCREB expression within GnRH neurons at 1 hr
(Fig. 1C) with no
change in CREB (data not shown). Again, this response was observed in GnRH
neurons located in the MS, rPOA, and AH, and the numbers of GnRH neurons were
not altered by E2 treatment (data not shown).
Estrogen acts directly on GnRH neurons to phosphorylate CREB
An acute brain slice paradigm was developed to further evaluate the
mechanism of CREB phosphorylation in GnRH neurons by estrogen.
Immunocytochemical analysis of these brain slices showed them to have numbers
of GnRH neurons equivalent to those found in vivo (e.g., GnRH
neurons/rPOA section, 18 ± 1 in vivo vs 17 ± 1 in
vitro).
Are the effects of E2 direct on the GnRH neurons?
The treatment of brain slices with 100 nM E2 for 1 hr
significantly (p < 0.05) elevated pCREB expression in GnRH neurons
(Fig. 2A,B) in a
manner similar to that found in vivo
(Fig. 1). Although reduced in
magnitude, this response was maintained in the presence of TTX
(Fig. 2A), which
electrically isolates GnRH neurons. Levels of CREB in GnRH neurons were not
changed by E2 or TTX (data not shown).

View larger version (51K):
[in this window]
[in a new window]
|
Figure 2. In vitro studies. Estrogen-dependent phosphorylation of CREB in
GnRH neurons is direct and requires estrogen to pass into the cell.
A, Histograms show the percentage of GnRH neurons expressing pCREB 1
hr after vehicle (V) (open bars) or 100 nM E2 (filled bars) in the
presence of normal ACSF or with the addition of 0.5 µM TTX.
B, Photomicrograph showing a single double-labeled GnRH plus pCREB
neuron from the in vitro slice preparation. Scale bar, 20 µm.
C, D, Histograms show the percentage of GnRH neurons expressing pCREB
(C) or CREB (D) 1 hr after administration of vehicle (open
bars), 100 nM E2BSA (hatched bars), or 100 nM E2
(filled bars). *p < 0.05; n = 46 in all
of the groups. Histograms show mean ± SEM.
|
|
Does E2 act at the cell membrane?
The cell-impermeant E2BSA compound is commonly used to define E2
actions that occur through estrogen-binding receptors that exist on the outer
surface of the cell membrane (Kelly and
Levin, 2001
). Whereas 100 nM E2 significantly
(p < 0.05) increased pCREB expression in GnRH neurons, 100
nM E2BSA was not found to have any effect
(Fig. 2C). The levels
of CREB in GnRH neurons were not altered by E2 or E2BSA
(Fig. 2D).
Estrogen requires ER
to phosphorylate CREB in GnRH neurons
To evaluate whether the estrogen-dependent phosphorylation of CREB in GnRH
neurons requires one of the classical ERs, we undertook experiments using
ER
KO and ER
KO mice. The previous study showed that
pCREB levels were likely to be maximal at 1 hr, so we used the lower 1 µg
E2 dose at 1 hr to evaluate ERKO mice. As found in wild-type C57BL/6J x
CBA/Ca mice (Fig. 1C),
the treatment of OVX wild-type (C57BL/6J) littermates of the knock-out mice
with 1 µg of E2 significantly (p < 0.05) increased pCREB
expression in GnRH neurons at 1 hr (Fig.
3A). The same effect was observed in OVX ER
KO mice
(p < 0.05), but E2 failed to change pCREB expression in GnRH
neurons in OVX ER
KO mice (Fig.
3A). The levels of pCREB in GnRH neurons of
vehicle-treated mice were not significantly different in the three genotypes.
In all three experimental groups, the levels of CREB immunoreactivity in GnRH
neurons were not altered by E2 treatment
(Fig. 3B). The
patterns of CREB and pCREB expression in GnRH neurons were the same regardless
of their location in the MS, rPOA, or AH, and the numbers of GnRH neurons
detected in all three genotypes were identical and not changed by E2 treatment
(data not shown). To evaluate the effect of E2 on the activity of the
hypothalamopituitary axis, plasma LH levels were determined in these mice. E2
significantly (p < 0.05) suppressed LH levels in wild-type mice
(vehicle, 9 ± 1.4 ng/ml; E2, 2.6 ± 0.2 ng/ml) but had no effect
on LH levels in ER
KO (vehicle, 3.0 ± 1.0 ng/ml; E2, 2.3 ±
0.5 ng/ml) or ER
KO (vehicle, 2.1 ± 0.5 ng/ml; E2, 2.9 ±
0.6 ng/ml) mice.
To evaluate further the role of ER
in estrogen-dependent CREB
phosphorylation, we performed an analysis of CREB and pCREB expression in the
AVPV and CA1 hippocampus of the sections used above for analysis of the GnRH
neurons. In rats, the AVPV expresses both ER
and ER
, whereas
ER
is the predominant ER subtype in the CA1
(Shughrue et al., 1997
). As
shown previously in rats (Gu et al.,
1996
; Carlstrom et al.,
2001
), estrogen was found to acutely elevate CREB phosphorylation
in the AVPV and CA1 of wild-type mice (Fig.
4). Whereas this effect persisted in the AVPV, the pattern of CREB
phosphorylation in the CA1 was blocked completely in the ER
KO but not
ER
KO mouse (Fig. 4). CREB expression was not altered significantly in either area by estrogen
treatment (data not shown).
Levels of pCREB remain elevated in intact female mice
To examine whether the rapid increase in the phosphorylation of CREB by
estrogen in GnRH neurons may be maintained under normal physiological
conditions of estrogen exposure, we compared OVX mice with intact females. As
observed in previous experiments, GnRH neurons in OVX mice (n = 6)
displayed low levels of pCREB. However, a fivefold greater number of GnRH
neurons were found to express pCREB in intact (diestrous; n = 6)
females (p < 0.05) (Fig.
5A). The increased numbers of pCREB plus GnRH neurons
were observed throughout the MS, rPOA, and AHA (not shown). Intact mice
displayed similar numbers of GnRH neurons to those found in 2 week OVX mice
(Fig. 5C), and,
similarly, CREB expression was not significantly different between the two
groups (Fig. 5B).

View larger version (18K):
[in this window]
[in a new window]
|
Figure 5. CREB phosphorylation is elevated in intact female mice in vivo.
Histograms show the percentage of GnRH neurons expressing pCREB (A)
and CREB (B) and the numbers of GnRH-immunoreactive neurons
(C) detected per section through the rPOA of OVX (open bars) and
intact diestrous female mice (filled bars). *p < 0.05;
n = 6 in all of the groups. Histograms show mean ± SEM.
|
|
 |
Discussion
|
|---|
We report here that GnRH neurons in the mouse respond to estrogen in a
rapid and direct manner through an ER
-dependent mechanism. The rapidity
of the actions of estrogen on CREB phosphorylation (<15 min) indicates a
nongenomic mechanism of action. Because the phosphorylation of CREB by
estrogen occurs directly at the GnRH neuron and is absent in ER
KO mice,
it is very likely that estrogen interacts with ER
expressed by GnRH
neurons. Such a scenario would be in good agreement with evidence for the
expression of ER
, but not ER
, in GnRH neurons
(Herbison and Pape, 2001
). A
common theme in the investigation of the GnRH neuronal phenotype is that of
marked heterogeneity (Sim et al.,
2001
), and once again, we find here that only a subpopulation
(2540%) of all GnRH neurons, irrespective of location, respond to
estrogen. Studies in mice have shown that
20% of adult female GnRH
neurons express ER
transcripts
(Skynner et al., 1999
),
whereas work in the rat has demonstrated 5080% of GnRH neurons to
contain ER
immunoreactivity
(Hrabovszky et al., 2001
;
Kallo et al., 2001
). Although
the reasons for the relatively low numbers of GnRH neurons expressing CREB and
pCREB immunoreactivity in this study are at least in part methodological, it
remains that not all of the GnRH neurons respond in the same manner. The
physiological basis for this heterogeneity is not established.
Role of ERs in nongenomic effects of estrogen on the brain
Previous studies have identified rapid, nongenomic effects of estrogen on
the phosphorylation status and activity of multiple different signaling
pathways in the brain (Gu and Moss,
1996
; Gu et al.,
1996
; Mermelstein et al.,
1996
; Zhou et al.,
1996
; Kelly and Wagner,
1999
; Kelly et al.,
1999
; Singer et al.,
1999
; Bi et al.,
2000
; Singh et al.,
2000
; Cardona-Gomez et al.,
2002
; Ivanova et al.,
2002
). Although the role of established and novel estrogen-binding
receptors in these effects is currently under investigation, at least two
distinct mechanisms of nongenomic estrogen action appear to exist. In the
first, the binding of estrogen to an ER located within the cytoplasm appears
to enable direct activational proteinprotein interactions with key
upstream signaling molecules such as Src kinase
(Migliaccio et al., 2000
;
Kousteni et al., 2001
) and
PI3K (phosphatidylinositol 3-kinase)
(Simoncini et al., 2000
). In
the brain, this mechanism is typified by the neuroprotective actions of
estrogen, which nongenomically modify the MAPK (mitogen-activated protein
kinase) pathway to alter glutamatergic transmission
(Singer et al., 1999
;
Bi et al., 2000
;
Nethrapalli et al., 2001
).
Most, but not all (Singh et al.,
2000
), in vitro studies indicate that classical ERs are
required for the nongenomic activation of MAPK by estrogen
(Migliaccio et al., 2000
;
Kousteni et al., 2001
;
Wade et al., 2001
;
Song et al., 2002
), and in
vivo, estrogenic protection from ischemic injury is known to depend on
ER
specifically (Wise et al.,
2001
). The second mechanism involves the ability of cell
membrane-located classical and nonclassical ERs to signal estrogen status to
the cell (Razandi et al.,
1999
; Valverde et al.,
1999
; Nadal et al.,
2000
; Benten et al.,
2001
; Watson et al.,
2002
). Within the brain, this membrane-dependent mode of action is
thought to underlie the ability of estrogen to modulate G-protein-coupled
receptors using PKA (protein kinase A)- and PKC (protein kinase C)-dependent
pathways (Kelly and Wagner,
1999
).
Although liganded ER
had been demonstrated to be capable of
activating Src kinase (Migliaccio et al.,
2000
; Kousteni et al.,
2001
) and the MAPK pathway
(Wade et al., 2001
) in
vitro, no information existed on its potential to mediate rapid
nongenomic effects of estrogen in vivo in the brain or elsewhere.
Indeed, when examined selectively, ER
was found to be ineffective
compared with ER
in mediating rapid estrogen actions in specific
signaling pathways (Hisamoto et al.,
2001
). Using the GnRH neuronal phenotype, we now show that the
rapid phosphorylation of CREB by estrogen is critically dependent on ER
in vivo. Although we can be less certain about the mechanisms through
which estrogen phosphorylates CREB in the CA1 hippocampus, it appears that
ER
is also responsible for mediating acute estrogen actions in this
region. This is clearly not the case in the AVPV where the phosphorylation of
CREB was maintained in the ER
KO mouse. Thus, it seems likely that
ER
may have a global role to play in mediating acute estrogen actions
and, in this regard, may be of particular importance to brain regions and
neuronal phenotypes that preferentially express ER
.
The inability of cell-impermeant E2BSA to replicate the effect of E2
alone in GnRH neurons suggests that either the coupling of estrogen to BSA may
alter its receptor binding or estrogen needs to pass through the GnRH neuron
cell membrane to influence signaling cascades. Because the E2BSA
preparation has been shown previously to activate classical ERs expressed in
the cell membrane (Razandi et al.,
1999
), E2BSA in our experiments should have been able to
interact with ER
had it been located within the membrane of the GnRH
neuron. Because E2BSA elicited no response, we favor the concept that
estrogen must pass through the membrane and interact with ER
within the
cytoplasm of the GnRH neuron to regulate CREB phosphorylation. The precise
intracellular pathway involved in CREB phosphorylation by
estrogenER
is unknown and may involve cAMPPKA,
calciumcalmodulin protein kinases, and/or MAPKs
(Shaywitz and Greenberg, 1999
;
West et al., 2001
).
Role of ER
in estrogen feedback on the GnRH neuron
The mechanisms through which estrogen exerts critical feedback actions on
the GnRH neurons are poorly understood, and the presence of ERs in these
neurons has long been controversial
(Herbison and Pape, 2001
).
Recent studies have indicated that GnRH neurons express low levels of ER
transcript and protein (Skynner et al.,
1999
; Hrabovszky et al.,
2000
,
2001
;
Kallo et al., 2001
), the
functional significance of which has been in doubt. Together, the present
series of experiments provide evidence that ER
expressed by GnRH neurons
is functional in mediating rapid estrogen actions. Whether ER
is also
active in a classic transcriptional manner in these cells has yet to be
established. Although both rapid and classical genomic mechanisms of estrogen
signaling clearly exist within the brain
(Kelly and Levin, 2001
), the
relationship between the two is unclear. In this study, we evaluated whether
the rapid estrogenic activation of CREB phosphorylation uncovered here in GnRH
neurons may also exist under normal physiological conditions. Our results show
that the GnRH neurons in diestrous female mice display levels of CREB
phosphorylation that are the same as those of OVX mice given estrogen acutely.
This suggests that the rapid estrogen signaling to phosphorylate CREB may be
ongoing in a persistent manner within the GnRH neurons. Recently proposed
models for the coordination of nongenomic and genomic estrogen actions have
suggested that classical genomic actions are set on a background of rapid,
nongenomic signaling (Kousteni et al.,
2001
; Vasudevan et al.,
2001
). The current observations indicate that a continuous
background of rapid ER
-dependent signaling, with genomic consequences,
is likely to exist in GnRH neurons.
From a physiological perspective, the role of ER
in GnRH neuron
function is not yet established. It seems very likely that estrogen uses
indirect transsynaptic and glial cell-dependent mechanisms, probably involving
ER
, to influence the activity of the GnRH neuron
(Herbison, 1998
). However,
ER
expressed by these cells may also be of physiological relevance.
Homozygous ER
KO female mice exhibit subnormal fertility
(Krege et al., 1998
) and have
modestly elevated basal LH levels (A. E. Herbison and A. DorlingA. E.,
unpublished observations) suggestive of defective estrogen negative feedback.
Furthermore, despite the observation here that LH levels were not markedly
elevated in ERKO mice after ovariectomy, acute estrogen was not found to
suppress LH in ER
KO mice. Together, these findings suggest that ER
expressed by GnRH neurons and/or other cells is at least partly involved in
the negative feedback influence of estrogen on GnRH neurons. The genes
regulated by ER
in GnRH neurons, either directly through E2 response
elements or indirectly through cAMP response elements, are not yet
established. However, estrogen-dependent CREB phosphorylation has been shown
previously to have an important role in synaptic plasticity
(Murphy and Segal, 1997
), and,
interestingly, mice with a brain-specific creb1 knock-out are known
to be infertile (Mantamadiotis et al.,
2002
). However, as for ER
itself, the precise definition of
the role of CREB in the GnRH neurons awaits the production of GnRH-specific,
ER
- and CREB-deficient mice.
In summary, these studies provide the first demonstration that ER
can
underlie rapid, nongenomic effects of estrogen within the brain. The ability
of ER
to act as a classical transcription factor as well as a molecule
enabling rapid, nongenomic effects of estrogen on intracellular signaling
pathways makes it pivotal in orchestrating the impact of estrogen impact on
neuronal function. This will likely be of physiological importance to the GnRH
neuron and of particular relevance to neuronal phenotypes in regions such as
the cerebral cortex and hippocampus where ER
is the predominant ER.
 |
Footnotes
|
|---|
Received Feb. 20, 2003;
revised Apr. 16, 2003;
accepted Apr. 22, 2003.
This research was supported by the Biotechnology and Biological Sciences
Research Council and a Marie Curie Fellowship of the European Community Human
Potential Programme under contract number HPMF-CT-2000-00512. We thank Dr. R.
Benoit for the LR1 antiserum, Amber Dorling for radioimmunoassay work, and
Sandra Dye and members of SABU at The Babraham Institute for assistance with
mice.
Correspondence should be addressed to Dr. Allan E. Herbison, Centre for
Neuroendocrinology, Department of Physiology, University of Otago School of
Medical Sciences, P.O. Box 913, Dunedin, New Zealand. E-mail address:
allan.herbison{at}stonebow.otago.ac.nz.
I. M. Ábrahám's present address: Hungarian Academy of
Sciences, Neurobiology Research Group at Eötvös Loránd
University, Páymány P. st. 1/C, 1117, Budapest, Hungary.
Copyright © 2003 Society for Neuroscience
0270-6474/03/235771-07$15.00/0
 |
References
|
|---|
Benten WPM, Stephan C, Lieberherr M, Wunderlich F
(2001) Estradiol signaling via sequestrable surface receptors.
Endocrinology 142:
1669-1677.[Abstract/Free Full Text]
Bi R, Broutman G, Foy MR, Thompson RF, Baudry M (2000)
The tyrosine kinase and mitogen-activated protein kinase pathways mediate
multiple effects of estrogen in hippocampus. Proc Natl Acad Sci
USA 97:
3602-3607.[Abstract/Free Full Text]
Bronson FH (1981) The regulation of lutienizing
hormone secretion by estrogen: relationship among negative feedback, surge
potential, and male stimulation in juvenile, peripubertal, and adult female
mice. Endocrinology 108:
506-516.[Abstract/Free Full Text]
Cardona-Gomez G, Mendez P, Garcia-Segura LM (2002)
Synergistic interaction of estradiol and insulin-like growth factor-1 in the
activation of PI3K/Akt signaling in the adult rat hypothalamus. Mol
Brain Res 107:
80-88.[Medline]
Carlstrom L, Ke ZJ, Unnerstall JR, Cohen RS, Pandey SC
(2001) Estrogen modulation of the cyclic AMP response
element-binding protein pathway. Effects of long-term and acute treatments.
Neuroendocrinology 74:
227-243.[Web of Science][Medline]
Gu G, Moss RL (1996) 17
-Estradiol potentiates
kainate-induced currents via activation of the cAMP cascade. J
Neurosci 16:
3620-3629.[Abstract/Free Full Text]
Gu G, Rojo AA, Zee MC, Yu J, Simerly RB (1996)
Hormonal regulation of CREB phosphorylation in the anteroventral
periventricular nucleus. J Neurosci 16:
3035-3044.[Abstract/Free Full Text]
Han SK, Abraham IM, Herbison AE (2002) Effect of GABA
on GnRH neurons switches from depolarization to hyperpolarization at puberty
in the female mouse. Endocrinology 143:
1459-1466.[Abstract/Free Full Text]
Henderson VW (2000) Oestrogens and dementia.
Novartis Found Symp 230:
254-265.[Medline]
Herbison AE (1998) Multimodal influence of estrogen
upon gonadotropin-releasing hormone neurons. Endocr Rev
19: 302-330.[Abstract/Free Full Text]
Herbison AE, Pape JR (2001) New evidence for estrogen
receptors in gonadotropin-releasing hormone neurons. Front
Neuroendocrinol 22:
292-308.[Web of Science][Medline]
Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y,
Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y
(2001) Estrogen induces the Akt-dependent activation of
endothelial nitricoxide synthase in vascular endothelial cells. J Biol
Chem 276:
3459-3467.[Abstract/Free Full Text]
Hrabovszky E, Shughrue PJ, Merchenthaler I, Hajszan T, Carpenter
CD, Liposits Z, Petersen SL (2000) Detection of estrogen
receptor-
messenger ribonucleic acid and 125I-estrogen
binding sites in luteinizing hormone-releasing hormone neurons of the rat
brain. Endocrinology 141:
3506-3509.[Abstract/Free Full Text]
Hrabovszky E, Steinhauser A, Barabas K, Shughrue PJ, Petersen SL,
Merchenthaler I, Liposits Z (2001) Estrogen receptor-
immunoreactivity in luteinizing hormone-releasing hormone neurons of the rat
brain. Endocrinology 142:
3261-3264.[Abstract/Free Full Text]
Ivanova T, Mendez P, Garcia-Segura LM, Beyer C (2002)
Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing
midbrain neurones by oestrogen. J Neuroendocrinol
14: 73-79.[Web of Science][Medline]
Kallo I, Butler JA, Barkovics-Kallo M, Goubillon ML, Coen CW
(2001) Oestrogen receptor
-immunoreactivity in gonadotropin
releasing hormone-expressing neurones: regulation by oestrogen. J
Neuroendocrinol 13:
741-748.[Web of Science][Medline]
Kelly MJ, Levin ER (2001) Rapid actions of plasma
membrane estrogen receptors. Trends Endocrinol Metab
12: 152-156.[Web of Science][Medline]
Kelly MJ, Wagner EJ (1999) Estrogen modulation of
G-protein-coupled receptors. Trends Endocrinol Metab
10: 369-374.[Web of Science][Medline]
Kelly MJ, Lagrange AH, Wagner EJ, Rønnekleiv OK
(1999) Rapid effects of estrogen to modulate G protein-coupled
receptors via activation of protein kinase A and protein kinase C pathways.
Steroids 64:
64-75.[Web of Science][Medline]
Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodmenner DL, Han L,
Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Robertson PK,
Weinstein RS, Jilka RL, Mangolagas SC (2001) Nongenotropic,
sex-nonspecific signaling through the estrogen or androgen receptors:
dissociation from transcriptional activity. Cell
104: 719-730.[Web of Science][Medline]
Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Magler JF, Sar
M, Korach KS, Gustafsson J-A, Smithies O (1998) Generation and
reproductive phenotypes of mice lacking estrogen receptor
. Proc
Natl Acad Sci USA 95:
15677-15682.[Abstract/Free Full Text]
Lagrange AH, Rønnekleiv OK, Kelly MJ (1995)
Estradiol-17
and µ-opioid peptides rapidly hyperpolarize GnRH
neurons: a cellular mechanism of negative feedback.
Endocrinology 136:
2341-2344.[Abstract]
Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O
(1993) Alteration of reproductive function but not prenatal
sexual development after insertional disruption of the mouse estrogen receptor
gene. Proc Natl Acad Sci USA 90:
11162-11166.[Abstract/Free Full Text]
Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O,
Villalba AM, Tronche F, Kellendonk C, Gau D, Kapfhammer J, Otto C, Schmid W,
Schutz G (2002) Disruption of CREB function in brain leads to
neurodegeneration. Nat Genet 31:
47-54.[Web of Science][Medline]
McEwen BS, Alves SE (1999) Estrogen actions in the
central nervous system. Endocr Rev 20:
279-307.[Abstract/Free Full Text]
McNulty S, Schurov IL, Sloper PJ, Hastings MH (1998)
Stimuli which entrain the circadian clock of the neonatal Syrian hamster in
vivo regulate the phosphorylation of the transcription factor CREB in the
suprachiasmatic nucleus in vitro. Eur J Neurosci
10: 1063-1072.[Web of Science][Medline]
Mermelstein PG, Becker JB, Surmeier DJ (1996)
Estradiol reduces calcium currents in rat neostriatal neurons via a membrane
receptor. J Neurosci 16:
595-604.[Abstract/Free Full Text]
Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A,
Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F
(2000) Steroid-induced androgen receptor-oestradiol receptor
-Src complex triggers prostate cancer cell proliferation. EMBO
J 19:
5406-5417.[Web of Science][Medline]
Murphy DD, Segal M (1997) Morphological plasticity of
dendritic spines in central neurons is mediated by activation of cAMP response
element binding protein. Proc Natl Acad Sci USA
94: 1482-1487.[Abstract/Free Full Text]
Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B
(2000) Nongenomic actions of estrogens and xenoestrogens by
binding at a plasma membrane receptor unrelated to estrogen receptor
and estrogen receptor
. Proc Natl Acad Sci USA
97: 11603-11608.[Abstract/Free Full Text]
Nethrapalli IS, Singh M, Guan X, Guo Q, Lubahn DB, Korach KS,
Toran-Allerand CD (2001) Estradiol (E2) elicits Src
phosphorylation in the mouse neocortex: the initial event in E2 activation of
the MAPK cascade? Endocrinology 142:
5145-5148.[Abstract/Free Full Text]
Pape J-R, Skynner MJ, Allen ND, Herbison AE (1999)
Transgenics identify distal 5'- and 3' sequences specifying
gonadotropin-releasing hormone expression in adult mice. Mol
Endocrinol 13:
2203-2211.[Abstract/Free Full Text]
Paxinos G, Franklin KBJ (2001) The mouse brain in
stereotaxic coordinates. San Diego: Academic.
Pfaff DW, Schwartz-Giblin S, McCarthy MM, Kow L-M
(1994) Cellular and molecular mechanisms of female reproductive
behaviors. In: The physiology of reproduction (Knobil E, Neill
JD, eds). New York: Raven.
Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell
membrane and nuclear estrogen receptors (ERs) originate from a single
transcript: studies of ER
and ER
expressed in Chinese hamster
ovary cells. Mol Endocrinol 13:
307-319.[Abstract/Free Full Text]
Shaywitz AJ, Greenberg ME (1999) CREB: a
stimulus-induced transcription factor activated by a diverse array of
extracellular signals. Annu Rev Biochem
68: 821-861.[Web of Science][Medline]
Shughrue PJ, Lane MV, Merchenthaler I (1997)
Comparative distribution of estrogen receptor-
and -
mRNA in the
rat central nervous system. J Comp Neurol
388: 507-525.[Web of Science][Medline]
Sim JA, Skynner MJ, Herbison AE (2001) Heterogeneity
in the basic membrane properties of postnatal gonadotropin-releasing hormone
neurons in the mouse. J Neurosci 21:
1067-1075.[Abstract/Free Full Text]
Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Llao JK
(2000) Interaction of oestrogen receptor with the regulatory
subunit of phosphatidylinositol-3-OH kinase. Nature
407: 538-541.[Medline]
Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM
(1999) The mitogen-activated protein kinase pathway mediates
estrogen neuroprotection after glutamate toxicity in primary cortical neurons.
J Neurosci 19:
2455-2463.[Abstract/Free Full Text]
Singh M, Setalo GJ, Guan X, Frail DE, Toran-Allerand CD
(2000) Estrogen-induced activation of the mitogen-activated
protein kinase cascade in the cerebral cortex of estrogen receptor-
knock-out mice. J Neurosci 20:
1694-1700.[Abstract/Free Full Text]
Skynner MJ, Sim JS, Herbison AE (1999) Detection of
estrogen receptor
and
messenger ribonucleic acids in adult
gonadotropin-releasing hormone neurons. Endocrinology
140: 5195-5201.[Abstract/Free Full Text]
Song RX-D, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen
RJ (2002) Linkage of rapid estrogen action to MAPK activation by
ER
-Shc association and Shc pathway activation.
Endocrinology 16:
116-127.
Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE
(1999) Differential effects of estradiol and estradiol-BSA
conjugates. Endocrinology 140:
5455-5458.[Abstract/Free Full Text]
Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI,
Mann GE, Vergara C, Latorre R (1999) Acute activation of maxi-K
channels (hSlo) by estradiol binding to the
subunit.
Science 285:
1929-1931.[Abstract/Free Full Text]
Vasudevan N, Kow LM, Pfaff DW (2001) Early membrane
estrogenic effects required for full expression of slower genomic actions in a
nerve cell line. Proc Natl Acad Sci USA
98: 12267-12271.[Abstract/Free Full Text]
von Gall C, Duffield GE, Hastings MH, Kopp MD, Dehghani F, Korf HW,
Stehle JH (1998) CREB in the mouse SCN: a molecular interface
coding the phase-adjusting stimuli light, glutamate, PACAP, and melatonin for
clockwork access. J Neurosci 18:
10389-10397.[Abstract/Free Full Text]
Wade CB, Robinson S, Shapiro RA, Dorsa DM (2001)
Estrogen receptor (ER)
and ER
exhibit unique pharmacologic
properties when coupled to activation of the mitogen-activated protein kinase
pathway. Endocrinology 142:
2336-2342.[Abstract/Free Full Text]
Watson CS, Campbell CH, Gametchu B (2002) The dynamic
and elusive membrane estrogen receptor-
. Steroids
67: 429-437.[Web of Science][Medline]
West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz
AJ, Takasu MA, Tao X, Greenberg ME (2001) Calcium regulation of
neuronal gene expression. Proc Natl Acad Sci USA
98: 11024-11031.[Abstract/Free Full Text]
Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M, Rosewell KL
(2001) Estradiol is a protective factor in the adult and aging
brain: understanding of mechanisms derived from in vivo and in vitro studies.
Brain Res Rev 37:
313-319.[Medline]
Zhou Y, Watters JJ, Dorsa DM (1996) Estrogen rapidly
induces the phosphorylation of the cAMP response element binding protein in
rat brain. Endocrinology 137:
2163-2166.[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
S. Soriano, A. B. Ropero, P. Alonso-Magdalena, C. Ripoll, I. Quesada, B. Gassner, M. Kuhn, J.-A. Gustafsson, and A. Nadal
Rapid Regulation of KATP Channel Activity by 17{beta}-Estradiol in Pancreatic {beta}-Cells Involves the Estrogen Receptor {beta} and the Atrial Natriuretic Peptide Receptor
Mol. Endocrinol.,
December 1, 2009;
23(12):
1973 - 1982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Herbison
Rapid actions of oestrogen on gonadotropin-releasing hormone neurons; from fantasy to physiology?
J. Physiol.,
November 1, 2009;
587(21):
5025 - 5030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sun, S. Kumar, J. Tian, and S. M. Black
Estradiol Increases Guanosine 5'-Triphosphate Cyclohydrolase Expression Via the Nitric Oxide-Mediated Activation of Cyclic Adenosine 5'-Monophosphate Response Element Binding Protein
Endocrinology,
August 1, 2009;
150(8):
3742 - 3752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Chu, J. Andrade, M. A. Shupnik, and S. M. Moenter
Differential Regulation of Gonadotropin-Releasing Hormone Neuron Activity and Membrane Properties by Acutely Applied Estradiol: Dependence on Dose and Estrogen Receptor Subtype
J. Neurosci.,
April 29, 2009;
29(17):
5616 - 5627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zhao, C. Park, M. A. McDevitt, C. Glidewell-Kenney, P. Chambon, J. Weiss, J. L. Jameson, and J. E. Levine
p21-Activated kinase mediates rapid estradiol-negative feedback actions in the reproductive axis
PNAS,
April 28, 2009;
106(17):
7221 - 7226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Christian, C. Glidewell-Kenney, J. L. Jameson, and S. M. Moenter
Classical Estrogen Receptor {alpha} Signaling Mediates Negative and Positive Feedback on Gonadotropin-Releasing Hormone Neuron Firing
Endocrinology,
November 1, 2008;
149(11):
5328 - 5334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Romano, K. Lee, I. M. Abraham, C. L. Jasoni, and A. E. Herbison
Nonclassical Estrogen Modulation of Presynaptic GABA Terminals Modulates Calcium Dynamics in Gonadotropin-Releasing Hormone Neurons
Endocrinology,
November 1, 2008;
149(11):
5335 - 5344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Roa, E. Vigo, J. M. Castellano, F. Gaytan, V. M. Navarro, E. Aguilar, F. A. Dijcks, A. G. H. Ederveen, L. Pinilla, P. I. van Noort, et al.
Opposite Roles of Estrogen Receptor (ER)-{alpha} and ER{beta} in the Modulation of Luteinizing Hormone Responses to Kisspeptin in the Female Rat: Implications for the Generation of the Preovulatory Surge
Endocrinology,
April 1, 2008;
149(4):
1627 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abe, K. L. Keen, and E. Terasawa
Rapid Action of Estrogens on Intracellular Calcium Oscillations in Primate Luteinizing Hormone-Releasing Hormone-1 Neurons
Endocrinology,
March 1, 2008;
149(3):
1155 - 1162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bouskine, M. Nebout, B. Mograbi, F. Brucker-Davis, C. Roger, and P. Fenichel
Estrogens Promote Human Testicular Germ Cell Cancer through a Membrane-Mediated Activation of Extracellular Regulated Kinase and Protein Kinase A
Endocrinology,
February 1, 2008;
149(2):
565 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Boulware, H. Kordasiewicz, and P. G. Mermelstein
Caveolin Proteins Are Essential for Distinct Effects of Membrane Estrogen Receptors in Neurons
J. Neurosci.,
September 12, 2007;
27(37):
9941 - 9950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Grattan, C. L. Jasoni, X. Liu, G. M. Anderson, and A. E. Herbison
Prolactin Regulation of Gonadotropin-Releasing Hormone Neurons to Suppress Luteinizing Hormone Secretion in Mice
Endocrinology,
September 1, 2007;
148(9):
4344 - 4351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hrabovszky, I. Kallo, N. Szlavik, E. Keller, I. Merchenthaler, and Z. Liposits
Gonadotropin-Releasing Hormone Neurons Express Estrogen Receptor-{beta}
J. Clin. Endocrinol. Metab.,
July 1, 2007;
92(7):
2827 - 2830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Speert, A. T. M. Konkle, S. L. Zup, J. M. Schwarz, C. Shiroor, M. E. Taylor, and M. M. McCarthy
Focal Adhesion Kinase and Paxillin: Novel Regulators of Brain Sexual Differentiation?
Endocrinology,
July 1, 2007;
148(7):
3391 - 3401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Vasudevan and D. W. Pfaff
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Endocr. Rev.,
February 1, 2007;
28(1):
1 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Lu, J.-C. Hsieh, M.-L. Tsaur, Y.-H. Huang, P. S. Wang, L.-L. Wu, P.-Y. Liu, F.-Y. Chang, and S.-D. Lee
Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: a role of CREB phosphorylation in spinal dorsal horn neurons
Am J Physiol Gastrointest Liver Physiol,
January 1, 2007;
292(1):
G438 - G446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohshiro, S. K. Rayala, M. D. Williams, R. Kumar, and A. K. El-Naggar
Biological Role of Estrogen Receptor {beta} in Salivary Gland Adenocarcinoma Cells.
Clin. Cancer Res.,
October 15, 2006;
12(20):
5994 - 5999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. El-Etr, Y. Akwa, E.-E. Baulieu, and M. Schumacher
The Neuroactive Steroid Pregnenolone Sulfate Stimulates the Release of Gonadotropin-Releasing Hormone from GT1-7 Hypothalamic Neurons, through N-Methyl-D-Aspartate Receptors
Endocrinology,
June 1, 2006;
147(6):
2737 - 2743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Szego, K. Barabas, J. Balog, N. Szilagyi, K. S. Korach, G. Juhasz, and I. M. Abraham
Estrogen Induces Estrogen Receptor {alpha}-Dependent cAMP Response Element-Binding Protein Phosphorylation via Mitogen Activated Protein Kinase Pathway in Basal Forebrain Cholinergic Neurons In Vivo
J. Neurosci.,
April 12, 2006;
26(15):
4104 - 4110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Pak, W. C. J. Chung, J. L. Roberts, and R. J. Handa
Ligand-Independent Effects of Estrogen Receptor {beta} on Mouse Gonadotropin-Releasing Hormone Promoter Activity
Endocrinology,
April 1, 2006;
147(4):
1924 - 1931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Kriegsfeld, D. F. Mei, G. E. Bentley, T. Ubuka, A. O. Mason, K. Inoue, K. Ukena, K. Tsutsui, and R. Silver
Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals
PNAS,
February 14, 2006;
103(7):
2410 - 2415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pompolo, A. Pereira, K. M. Estrada, and I. J. Clarke
Colocalization of Kisspeptin and Gonadotropin-Releasing Hormone in the Ovine Brain
Endocrinology,
February 1, 2006;
147(2):
804 - 810.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bodo, A. E. Kudwa, and E. F. Rissman
Both Estrogen Receptor-{alpha} and -{beta} Are Required for Sexual Differentiation of the Anteroventral Periventricular Area in Mice
Endocrinology,
January 1, 2006;
147(1):
415 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Couse, M. M. Yates, B. J. Deroo, and K. S. Korach
Estrogen Receptor-{beta} Is Critical to Granulosa Cell Differentiation and the Ovulatory Response to Gonadotropins
Endocrinology,
August 1, 2005;
146(8):
3247 - 3262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Dhandapani, F. M. Wade, V. B. Mahesh, and D. W. Brann
Astrocyte-Derived Transforming Growth Factor-{beta} Mediates the Neuroprotective Effects of 17{beta}-Estradiol: Involvement of Nonclassical Genomic Signaling Pathways
Endocrinology,
June 1, 2005;
146(6):
2749 - 2759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Merchenthaler, G. E. Hoffman, and M. V. Lane
Estrogen and Estrogen Receptor-{beta} (ER{beta})-Selective Ligands Induce Galanin Expression within Gonadotropin Hormone-Releasing Hormone-Immunoreactive Neurons in the Female Rat Brain
Endocrinology,
June 1, 2005;
146(6):
2760 - 2765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Matagne, M.-C. Lebrethon, A. Gerard, and J.-P. Bourguignon
Kainate/Estrogen Receptor Involvement in Rapid Estradiol Effects in Vitro and Intracellular Signaling Pathways
Endocrinology,
May 1, 2005;
146(5):
2313 - 2323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Clarke, V. A. Tobin, S. Pompolo, and A. Pereira
Effects of Changing Gonadotropin-Releasing Hormone Pulse Frequency and Estrogen Treatment on Levels of Estradiol Receptor-{alpha} and Induction of Fos and Phosphorylated Cyclic Adenosine Monophosphate Response Element Binding Protein in Pituitary Gonadotropes: Studies in Hypothalamo-Pituitary Disconnected Ewes
Endocrinology,
March 1, 2005;
146(3):
1128 - 1137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Temple and S. Wray
Bovine Serum Albumin-Estrogen Compounds Differentially Alter Gonadotropin-Releasing Hormone-1 Neuronal Activity
Endocrinology,
February 1, 2005;
146(2):
558 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Chakraborty, G. Rajendren, and A. C. Gore
Expression of Estrogen Receptor {alpha} in the Anteroventral Periventricular Nucleus of Hypogonadal Mice
Experimental Biology and Medicine,
January 1, 2005;
230(1):
49 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-M. Kow and D. W. Pfaff
The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions
PNAS,
August 17, 2004;
101(33):
12354 - 12357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Chaban, A. J. Lakhter, and P. Micevych
A Membrane Estrogen Receptor Mediates Intracellular Calcium Release in Astrocytes
Endocrinology,
August 1, 2004;
145(8):
3788 - 3795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Temple, E. Laing, A. Sunder, and S. Wray
Direct Action of Estradiol on Gonadotropin-Releasing Hormone-1 Neuronal Activity via a Transcription-Dependent Mechanism
J. Neurosci.,
July 14, 2004;
24(28):
6326 - 6333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. McCarthy
Out with the New, in with the Old: Classical Estrogen Receptors Mediate Novel Estradiol Actions in Brain
Endocrinology,
July 1, 2004;
145(7):
3053 - 3054.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Abraham, M. G. Todman, K. S. Korach, and A. E. Herbison
Critical in Vivo Roles for Classical Estrogen Receptors in Rapid Estrogen Actions on Intracellular Signaling in Mouse Brain
Endocrinology,
July 1, 2004;
145(7):
3055 - 3061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Dellovade and I. Merchenthaler
Estrogen Regulation of Neurokinin B Gene Expression in the Mouse Arcuate Nucleus Is Mediated by Estrogen Receptor {alpha}
Endocrinology,
February 1, 2004;
145(2):
736 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|